DORAvirine Versus DOlutegravir Based Antiretroviral Regimens in Treatment-na ïve People Living With HIV-1 Infection

Conditions: HIV-1-infection Interventions: Drug: Doravirine + tenofovir DF + lamivudine; Drug: Dolutegravir + tenofovir DF + lamivudine or emtricitabine Sponsors: ANRS, Emerging Infectious Diseases; MSD France Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials